IL157470A0 - Isoxazoline derivatives as anti-depressants - Google Patents

Isoxazoline derivatives as anti-depressants

Info

Publication number
IL157470A0
IL157470A0 IL15747002A IL15747002A IL157470A0 IL 157470 A0 IL157470 A0 IL 157470A0 IL 15747002 A IL15747002 A IL 15747002A IL 15747002 A IL15747002 A IL 15747002A IL 157470 A0 IL157470 A0 IL 157470A0
Authority
IL
Israel
Prior art keywords
depressants
isoxazoline derivatives
isoxazoline
derivatives
Prior art date
Application number
IL15747002A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica N V Jans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N V Jans filed Critical Janssen Pharmaceutica N V Jans
Publication of IL157470A0 publication Critical patent/IL157470A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15747002A 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants IL157470A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05
PCT/EP2002/001567 WO2002066484A1 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants

Publications (1)

Publication Number Publication Date
IL157470A0 true IL157470A0 (en) 2004-03-28

Family

ID=26076836

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15747002A IL157470A0 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants
IL157470A IL157470A (en) 2001-02-21 2003-08-19 History of isoxazoline used as antidepressants

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157470A IL157470A (en) 2001-02-21 2003-08-19 History of isoxazoline used as antidepressants

Country Status (33)

Country Link
US (1) US7169786B2 (xx)
EP (1) EP1368358B1 (xx)
JP (1) JP3953424B2 (xx)
KR (1) KR100848898B1 (xx)
CN (1) CN100400540C (xx)
AR (1) AR035685A1 (xx)
AT (1) ATE337322T1 (xx)
AU (1) AU2002244717B2 (xx)
BG (1) BG107984A (xx)
BR (1) BR0207433A (xx)
CA (1) CA2437505C (xx)
CY (1) CY1106448T1 (xx)
CZ (1) CZ20032515A3 (xx)
DE (1) DE60214138T2 (xx)
DK (1) DK1368358T3 (xx)
EA (1) EA006747B1 (xx)
EE (1) EE200300398A (xx)
EG (1) EG23929A (xx)
ES (1) ES2271230T3 (xx)
HK (1) HK1065537A1 (xx)
HR (1) HRP20030647A2 (xx)
HU (1) HUP0303270A3 (xx)
IL (2) IL157470A0 (xx)
MX (1) MXPA03007432A (xx)
MY (1) MY137836A (xx)
NO (1) NO20033700L (xx)
NZ (1) NZ526741A (xx)
PL (1) PL208593B1 (xx)
PT (1) PT1368358E (xx)
SI (1) SI1368358T1 (xx)
SK (1) SK11612003A3 (xx)
TW (1) TWI257392B (xx)
WO (1) WO2002066484A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
EA008189B1 (ru) * 2002-04-02 2007-04-27 Янссен Фармацевтика Н.В. Замещенные производные аминоизоксазолина и их применение в качестве антидепрессантов
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ES2339444T3 (es) * 2002-08-15 2010-05-20 Janssen Pharmaceutica Nv Derivados de isoxazolina heterociclicos condensados y su uso como antidepresivos.
MY134287A (en) * 2002-08-21 2007-11-30 Janssen Pharmaceutica Nv C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
RU2333200C2 (ru) 2003-03-07 2008-09-10 Астеллас Фарма Инк. Азотсодержащие гетероциклические производные, содержащие 2,6-дизамещенный стирил
AU2004283196B2 (en) * 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
EP1905774B1 (en) * 2003-09-17 2013-02-20 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as serotonin receptor modulators
DE602005016836D1 (de) * 2004-11-26 2009-11-05 Janssen Pharmaceutica Nv Chotischer und anxiolytischer aktivität
EP2137193B1 (en) 2007-03-09 2017-08-09 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
US7863266B2 (en) * 2007-06-08 2011-01-04 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
JP2011507835A (ja) 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68906340T2 (de) 1988-09-19 1993-08-12 Akzo Nv Tetrahydronaphthalin und indan-derivate.
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
DK0892804T3 (da) * 1996-04-12 2002-12-02 Janssen Pharmaceutica Nv Isoxazolidin derivater
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
ES2216579T3 (es) * 1998-10-09 2004-10-16 Janssen Pharmaceutica N.V. Derivados de 4,5-dihidro-isoxazol y su uso farmaceutico.

Also Published As

Publication number Publication date
AU2002244717B2 (en) 2007-07-19
MXPA03007432A (es) 2003-11-18
SK11612003A3 (sk) 2004-04-06
DE60214138D1 (de) 2006-10-05
CZ20032515A3 (cs) 2003-12-17
NO20033700D0 (no) 2003-08-20
PL363264A1 (en) 2004-11-15
DK1368358T3 (da) 2007-01-02
ES2271230T3 (es) 2007-04-16
JP3953424B2 (ja) 2007-08-08
KR20030076590A (ko) 2003-09-26
MY137836A (en) 2009-03-31
PT1368358E (pt) 2007-01-31
NZ526741A (en) 2004-04-30
WO2002066484A1 (en) 2002-08-29
JP2004518748A (ja) 2004-06-24
US20040122037A1 (en) 2004-06-24
BG107984A (bg) 2004-09-30
CY1106448T1 (el) 2011-10-12
PL208593B1 (pl) 2011-05-31
ATE337322T1 (de) 2006-09-15
CA2437505C (en) 2010-02-09
HUP0303270A3 (en) 2007-03-28
EA200300915A1 (ru) 2004-06-24
US7169786B2 (en) 2007-01-30
EG23929A (en) 2008-01-14
IL157470A (en) 2008-07-08
DE60214138T2 (de) 2007-03-29
KR100848898B1 (ko) 2008-07-29
HK1065537A1 (en) 2005-02-25
SI1368358T1 (sl) 2007-02-28
NO20033700L (no) 2003-10-21
BR0207433A (pt) 2004-06-01
EP1368358A1 (en) 2003-12-10
HUP0303270A2 (hu) 2004-01-28
CN100400540C (zh) 2008-07-09
TWI257392B (en) 2006-07-01
HRP20030647A2 (en) 2005-06-30
EA006747B1 (ru) 2006-04-28
EP1368358B1 (en) 2006-08-23
EE200300398A (et) 2003-12-15
CN1492871A (zh) 2004-04-28
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
EG25755A (en) Oxazol deriatives
HU0401339D0 (en) Novel 4-anilinoquinoline-3-carboxamides
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
IL158388A0 (en) Novel arylheteroalkylamine derivatives
EP1353546A4 (en) METHOD AND DEVICE FOR MONITORING PULSATION FOR TREATMENT DEVICE
HUP0303449A3 (en) Substituted benzofuran-2-carboxamides derivatives
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
IL157470A0 (en) Isoxazoline derivatives as anti-depressants
HUP0303186A3 (en) 4-aminobenzopyran derivatives
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
GB0104554D0 (en) New uses
EP1384783A4 (en) NEW MAXIZYM
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
EG23036A (en) Novel pyrrolecarboxamides
GB0324680D0 (en) Cementitios mixtures
ZA200306487B (en) Isoxazoline derivatives as anti-depressants.
GB2388047B (en) Game
PL364076A1 (en) Novel pyridylmethylaminopyrimidines
GB0203683D0 (en) PAK-GFP Construct
GB0130856D0 (en) Game
CA93273S (en) Sparkler
GB0117866D0 (en) Cartenoid Expression
AU146824S (en) Hand puppet
AU146823S (en) Hand puppet

Legal Events

Date Code Title Description
KB Patent renewed